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INTRODUCTION
Early developmental events within the mammalian embryo
entail the formation of extra-embryonic cell lineages and the
construction of an embryonic environment in which later
development can proceed. The resulting blastocyst contains
two extraembryonic lineages, trophectoderm and primitive
endoderm with the embryo itself comprising a pool of
pluripotent cells located within the inner cell mass (ICM). As
development proceeds, pluripotent cells of the ICM undergo
rapid proliferation, selective apoptosis, differentiation and
reorganisation as they form a second pluripotent cell
population, the primitive ectoderm. In the mouse, pluripotent
cells of the ICM begin to proliferate rapidly around the time
of blastocyst implantation (4.75 days post coitum (d.p.c.)) and
expand into the blastocoelic cavity (Snow, 1977). Between 5.0
and 5.5 d.p.c. the inner cells of the pluripotent cell mass are
proposed to undergo apoptosis to form the proamniotic cavity
(Coucouvanis and Martin, 1995). The outer, surviving cells, or
primitive ectoderm, continue to proliferate and by 6.0-6.5
d.p.c. have formed a pseudo-stratified epithelial layer of
pluripotent cells. The primitive ectoderm gives rise to the germ
cells (Ginsburg et al., 1990) and, during gastrulation, acts as a
substrate for the generation of the primary germ layers of the
embryo proper and the extra-embryonic mesoderm (Gardner
and Rossant, 1979).
The development of pluripotent cells from ICM to primitive
ectoderm is poorly characterised, due to the small size,
complexity and inaccessibility of the mouse embryo within the
uterine environment. Developmental differences between the
ICM and primitive ectoderm have been reported by Gardner
and Rossant (1979) and Gardner (1985), who demonstrated
that the pluripotent cells of the embryo progressively lose
developmental potential such that primitive ectoderm (5.0
d.p.c.) can be distinguished from ICM by an inability to form
primitive endoderm. Furthermore, pluripotent cells of the post-
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The primitive ectoderm of the mouse embryo arises from
the inner cell mass between 4.75 and 5.25 days post coitum,
around the time of implantation. Positioned at a pivotal
time in development, just prior to formation of the three
germ layers of the embryo proper, the primitive ectoderm
responds directly to the signals generated during
gastrulation. We have identified a conditioned medium,
MEDII, which caused the homogeneous conversion of ES
cells to a morphologically distinct cell population, termed
early primitive ectoderm-like (EPL) cells. EPL cells
expressed the pluripotent cell markers Oct4, SSEA1 and
alkaline phosphatase. However, the formation of EPL cells
was accompanied by alterations in Fgf5, Gbx2 and Rex1
expression, a loss in chimaera forming ability, changes in
factor responsiveness and modified differentiation
capabilities, all consistent with the identification of EPL
cells as equivalent to the primitive ectoderm population of
the 5.5 to 6.0 days post coitum embryo. EPL cell formation
could be reversed in the presence of LIF and withdrawal
of MEDII, which suggested that EPL cell formation was not
a terminal differentiation event but reflected the ability of
pluripotent cells to adopt distinct cell states in response to
specific factors. Partial purification of MEDII revealed the
presence of two separable biological activities, both of
which were required for the induction and maintenance of
EPL cells.
We show here the first demonstration of uniform
differentiation of ES cells in response to biological factors.
The formation of primitive ectoderm, both in vivo and in
vitro, appears to be an obligatory step in the differentiation
of the inner cell mass or ES cells into cell lineages of the
embryonic germ layers. EPL cells potentially represent a
model for the development of lineage specific
differentiation protocols and analysis of gastrulation at a
molecular level. An understanding of the active
components of MEDII may provide a route for the
identification of factors which induce primitive ectoderm
formation in vivo.
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implantation embryo, but not the pre-implantation embryo, are
unable to contribute to development when introduced into host
blastocysts (Gardner, 1971; Rossant, 1977; Beddington, 1983;
Brook and Gardner, 1997). Compared to ICM, primitive
ectoderm exhibits an up regulation of the fibroblast growth
factor 5 gene (Fgf5) and down regulation of the zinc finger
gene, Rex1 (Haub and Goldfarb, 1991; Hébert et al., 1991;
Rogers et al., 1991). The analysis of gene expression by
wholemount in situ hybridisation, and the analysis of
developmental potential by transplantation studies, suggest that
pluripotent cells within primitive ectoderm remain
homogeneous until just prior to gastrulation (Beddington 1983;
Rosner et al., 1990; Haub and Goldberg, 1991; Hébert et al.,
1991). The possibility that additional, temporally defined,
pluripotent cell populations exist transiently between the ICM
and primitive ectoderm has not been resolved. Little is known
of the molecular signals involved in the development of
pluripotent cells but expression mapping studies, gene
knockouts and the analysis of in vitro assays suggest that
signals emanating from the primitive and visceral endoderm
are required for primitive ectoderm formation and
differentiation (Chen et al., 1994; Spyropoulos and Capecchi,
1994; Coucouvanis and Martin, 1995; Thomas and
Beddington, 1996).
Pluripotent cells can be isolated from the pre-implantation
mouse embryo as embryonic stem (ES) cells (Evans and
Kaufman, 1981; Martin, 1981; Smith and Hooper, 1987;
Nichols et al., 1990; Pease et al., 1990; Brook and Gardner,
1997). ES cells can be maintained indefinitely as a pluripotent
cell population in vitro in the presence cytokines of the IL-6
family (Williams et al., 1988; Smith et al., 1988; Gearing and
Bruce, 1992; Conovar et al., 1993; Pennica et al., 1995;
Yoshida et al., 1994), and, when reintroduced into a host
blastocyst, can contribute to all adult tissues of the mouse
including the germ cells (Robertson et al., 1986; Thomas and
Capecchi, 1987). ES cells, therefore, retain the ability to
respond to all the signals that regulate normal mouse
development, and potentially represent a powerful model
system for the investigation of mechanisms underlying
pluripotent cell biology and differentiation within the early
embryo.
Spontaneous differentiation of ES cells in culture, induced
either by the withdrawal of LIF or by differentiation in
response to chemical reagents, results in the formation of
heterogeneous arrays of terminally differentiated cell types
(Smith, 1991). The relevance of this differentiation to
development in vivo is questionable. Differentiation as
embryoid bodies, formed by cellular aggregation of ES cells,
results in reproducible and ordered generation of derivatives of
all three germ layers via a primitive ectoderm intermediate, and
appears to reflect many of the normal processes of embryonic
development (Shen and Leder, 1992; J.-A. Lake, J. Rathjen and
P. D. Rathjen, unpublished). Although the analysis of embryoid
body differentiation has shed some light on inductive signals
involved in primitive ectoderm formation and differentiation
to mesoderm (van den Eijnden-van Raaij et al., 1991;
Coucouvanis and Martin, 1995; Johansson and Wiles, 1995),
it involves the creation of a complex cellular environment in
which the characterisation of defined differentiation events is
difficult. Uniform differentiation of ES cells in response to
factors of biological origin, has not been reported, possibly
because ES cells, which are most like pluripotent cells of the
pre-implantation embryo, require prior differentiation to a
responsive intermediate, or primitive ectoderm-like cell (Shen
and Leder, 1992).
In this paper we report the differentiation of ES cells to a
homogeneous pluripotent cell population, termed early
primitive ectoderm-like (EPL) cells, in response to two
separable factors derived from medium conditioned by a
human hepatocellular carcinoma cell line. EPL cells have been
characterised by gene expression, chimera formation, factor
requirements and differentiation potential and found to be most
closely related to the primitive ectoderm of the pre-gastrulation
embryo. The action of MEDII appears to parallel the formation
of primitive ectoderm from the ICM, and EPL cells represent
an in vitro equivalent of the post-implantation primitive
ectoderm of the embryo, prior to 6.0 d.p.c. The transition of
ES cells to EPL cells occurred in the absence of cellular
aggregation and is the first report of factors which effect the




ES cells were cultured in the absence of feeders on tissue-culture
grade plastic-ware (Falcon) pre-treated with 0.2% gelatin/PBS for a
minimum of 30 minutes. Cells were cultured in Dulbecco’s modified
Eagles medium (DMEM; Gibco BRL #12800) supplemented with
10% foetal calf serum (FCS; Commonwealth Serum Laboratories), 40
mg/ml gentamycin, 1 mM L-glutamine, 0.1 mM b -mercaptoethanol
( b -ME) and 1000 units of LIF under 10% CO2 in a humidified
incubator. EPL cells were formed and maintained in media containing
50% MEDII conditioned medium in DMEM supplemented with 10%
FCS, 40 mg/ml gentamycin, 1 mM L-glutamine, 0.1 mM b -ME with
or without the addition of 1000 units of LIF. Routine tissue culture
was performed as described by Smith (1991). E14 ES cells (Hooper
et al., 1987) were obtained from Anna Michelska (Murdoch Institute,
Melbourne). CCE ES cells (Robertson et al., 1986) were obtained
from Richard Harvey (Walter and Eliza Hall Institute, Melbourne).
MBL5 (Pease et al., 1990) and D3 (Doetschman et al., 1985) ES cell
lines were obtained from Lindsay Williams (Ludwig Institute,
Melbourne). CGR8 and E14TG2a (Hooper et al., 1987) ES cells were
provided by Austin Smith (Centre for Genome Research, Edinburgh).
EPL formation was apparent with the addition of between 10% and
80% MEDII, however optimal culture conditions were observed at
50% (data not shown).
LIF was produced from COS-1 cells transfected with a mouse LIF
expression plasmid, pDR10, as described by Smith (1991) with the
following modifications. COS-1 cells were transfected by
electroporation using a Bio-Rad Gene Pulsar at 270 V and a
capacitance of 250 m D. Transfected cells were plated at 7 · 104
cells/cm2 in DMEM, pH 7.4, containing high glucose and
supplemented with 10% FCS, 40 mg/ml gentamycin and 1 mM L-
glutamine. Medium was collected and assayed for LIF expression as
described by Smith (1991).
Hep G2 cells (Knowles et al., 1980; ATCC HB-8065) were
maintained in culture in DMEM supplemented with 10% FCS, 40
mg/ml gentamycin and 1 mM L-glutamine and passaged at
confluence. To condition medium (MEDII) HepG2 cells were seeded
into DMEM supplemented with 10% FCS, 40 mg/ml gentamycin and
1 mM L-glutamine at a density of 5· 104 cells/cm2. Medium was
collected after 4-5 days, sterilised by filtration through a 0.22 m m
membrane and supplemented with 0.1 mM b -ME before use. MEDII
J. Rathjen and others
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was stored at 4°C for 1-2 weeks or at - 20°C for up to 6 months
without apparent loss of activity. To produce serum free MEDII
(sfMEDII) Hep G2 cells were seeded as above and cultured for three
days. Cells were washed twice with 1· PBS and once with serum free
medium (DMEM containing high glucose but without Phenol Red,
supplemented with 1 mM L-glutamine, 0.1 mM b -ME, 1 · ITSS
supplement (Boehringer Mannhiem), 10 mM Hepes, pH 7.4, and 110
mg/l sodium pyruvate) for 2 hours. Fresh serum free medium was
added at a ratio of 0.23 ml/cm2 and the cells cultured for a further 3-
4 days. SfMEDII was collected, sterilised and stored as for MEDII.
Northern blot and RNA protection analyses
Cytoplasmic RNA was isolated from cultured ES and EPL cell layers
using the method of Edwards et al. (1985). Northern blot analysis was
performed as described by Thomas et al. (1995). DNA probes were
prepared from DNA fragments using a Gigaprime labelling kit
(Bresagen). DNA fragments were isolated form the following
plasmids. An H19 cDNA fragment was excised from LC10-8 (from
Dr P. W. J. Rigby; Poirier et al., 1991) as a 778 bp fragment with
PvuII. A 462 bp StuI cDNA fragment of Oct4, spanning positions 491-
593, in bluescript was obtained from Dr H. Schöler (Schöler et al.,
1990). A 484 bp fragment was released by XhoI/HindIII digestion and
used for probe generation. A Brachyury specific probe was excised
from pSK75 (obtained from Dr B. G. Herrmann) as a 1600 bp EcoRI
fragment. F20A in pUC8, containing uvomorulin, was obtained from
Dr R. Kremler (Ringwald et al., 1987). An uvomorulin probe was
excised as a 620 bp EcoRI fragment. pAB11, containing Evx-1 cDNA
sequences, was obtained from Dr G. Martin (Dush and Martin, 1992).
A 700 bp PstI/BamHI Evx-1 cDNA fragment was used in northern
analysis. Fgf5 was obtained as a full length coding region clone in
Bluescript from Dr J. Hébert (Hébert et al., 1990), from which an 800
bp EcoRI/BamHI cDNA fragment was isolated and used as a probe.
AFP was obtained as a 400 bp EcoRI fragment, encoding the first 350
bp of the mouse AFP cDNA in pBKSII+ from Dr R. Krumlauf. Rex1
was obtained from Dr N. Clarke as a 848 bp PCR fragment cloned
into pCRTMII (Hosler et al., 1989). The 848 bp Rex1 probe was
excised from this plasmid by EcoRI digestion. A mGAP probe was
synthesised by labelling a whole plasmid containing 300 bp of mGAP
cDNA sequence (Rathjen et al., 1990).
RNA protection assays were performed as described by Chapman
et al. (1997). A riboprobe for the detection of Oct4 was transcribed
from the Oct4 containing plasmid described above which had been
linearised with NciI.
Wholemount in situ hybridisation
Wholemount in situ hybridisation on cell layers was performed using
the method of Rosen and Beddington (1993) with the following
modification. Cell layers were pre-hybridised, hybridised and washed
at 65°C. Cell layers were blocked with 10% heat inactivated FCS and
antibodies were added in TSBT/1% FCS. The antibodies were not pre-
adsorbed. Anti-sense Oct4 probes were synthesised by T3 RNA
polymerase as run-off transcripts from bluescript containing a 462 bp
StuI Oct4 cDNA fragment (Schöler et al., 1990), linearised with
HindIII. Sense transcripts, used as controls, were obtained from the
same plasmid linearised with XhoI and transcribed by T7 RNA
polymerase. Sense and anti-sense Fgf5 transcripts were generated
from a plasmid clone containing the full-length Fgf5 coding sequence
which had been linearised with either EcoRI or BamHI and
transcribed with T7 or T3 RNA polymerase respectively.
Alkaline phosphatase staining
Alkaline phosphatase was visualised using diagnostic kit 86-R
(Sigma). The kit was used according to the manufacturer’s
specifications with the following modification: cell layers were fixed
in 4.5 mM citric acid, 2.25 mM sodium citrate, 3 mM sodium chloride,
65% methanol and 4% para-formaldehyde prior to washing and
staining.
Blastocyst injection
ES and EPL cells were introduced to into CBA/C57 F2 blastocysts
using standard blastocyst injection technology, as described by
Stewart (1993). E14TG2a (Hooper et al., 1987) cells for injection
were grown for 2 and 4 days in either medium containing LIF or
MEDII before trypsinisation to a single cell suspension in preparation
for injection.
GPI analysis
GPI analysis of blood and tissues was described by Bradley (1987).
Blood samples were collected from the tail. The tissue samples
analysed were taken from the brain, eye, femur, heart, intestines,
kidneys, liver, lung, muscle, stomach, skin, spleen, tongue, thymus
and the ovary or testes. Tissues samples were prepared by
freeze/thawing and by homogenisation in water before analysis.
Column chromatography
Anion exchange column chromatography was performed using a
FPLC system fitted with a 1 ml Resource Q column (Pharmacia). 2
mg of protein (retained fraction) was bound in 50 mM Tris-Cl, pH
8.5, and eluted with an increasing concentration of 1 M NaCl in 50
mM Tris-Cl, pH 8.5, at a flow rate of 1 ml/minute over 40 minutes.
Proteins were detected at 280 nm. 1 ml fractions were collected across
the gradient, desalted and concentrated using Centricon-10 units
(Amicon) before being assayed for activity. Activity was assessed by
seeding 500 D3 ES cells into gelatin coated 1 ml tissue culture wells
containing 0.5 ml ES DMEM, 1000 units mLIF, 0.5 ml eluted fraction
(obtained by ultrafiltration of sfMEDII on a Centricon-10 unit;
Amicon) reconstituted to 10% FCS and the column fractions. After 5
days cells were stained for alkaline phosphatase and assessed for EPL
cell formation morphologically.
Normal phase chromatography was performed using a Waters 510
HPLC machine fitted with a 10 mm Waters radial pak normal phase
silica column. Eluted material was detected with a Waters 490E
programmable multi-wavelength detector set at 215 nm. The eluted
fraction, prepared by ultrafiltration of sfMEDII over a Centricon-10
unit (Amicon), was pre-treated on a Sephadex G10 column,
lyophilised and resuspended in 30:70 methanol:acetonitrile before
application to the column. Material was eluted using increasing
concentrations of water at a rate of 0.5 ml/minute. 1 ml fractions were
collected, lyophilised, resuspended in 50 m l DMEM and assayed for
activity. D3 ES cells were seeded as before into 1 ml ESDMEM, 1000
units LIF, 50 m g of retained fraction and the column fractions. Activity
was assessed as before.
RESULTS
MEDII effects the transition of ES to EPL cells
When grown in medium supplemented with recombinant
mouse LIF (mLIF) and in the absence of a feeder cell layer ES
cells grow as a homogeneous population with greater than 95%
of the colonies displaying a distinctive domed colony
morphology (Fig. 1A.; Pease et al., 1990; Conovar et al., 1993).
To assay for factors capable of inducing ES cell differentiation,
ES cells were seeded at a density of 250 cells/cm2 and cultured
in the presence of mLIF and conditioned medium derived from
mammalian cell lines. After 5 days the cells were assessed for
divergence from the ES cell colony morphology.
When cultured in the presence of 10-80% medium (MEDII)
conditioned by Hep G2 cells (Knowles et al., 1980; ATCC HB-
8065) ES cells gave rise to a morphologically distinct
population of cells, which we have termed early primitive
ectoderm-like, or EPL, cells. The formation of EPL cells was
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specific for MEDII and was not seen in response to any of
thirteen other conditioned media assayed. The EPL cell
morphology was observed both on gelatin coated plastic and
in co-culture with inactivated feeders (data not shown).
In contrast to the characteristic ES cell colony morphology,
EPL cells grew as monolayer colonies in which individual
cells, containing nuclei with one or more prominent nucleoli,
were easily discernible (Fig. 1B). Morphologically, EPL cells
resembled P19 embryonal carcinoma (EC) cells (McBurney
and Rogers, 1982; Rudnicki and McBurney, 1987), which are
considered similar to cells of post implantation primitive
ectoderm (van den Eijnden-van Raaij, 1991; Rogers et al.,
1991). The culture of ES cells in the presence of 50%
MEDII+mLIF resulted in a relatively homogeneous cell
population in which greater than 95% of colonies were of the
EPL cell colony morphology and in which no residual ES cell
colonies could be detected (Fig. 1C). In the absence of added
LIF 77% of the colonies were morphologically EPL cells with
the remaining 23% of colonies comprising overtly
differentiated cell types (Fig. 1C). This instability was not
observed when EPL cells were formed or maintained at high
densities in MEDII without added mLIF (data not shown). The
formation of a relatively uniform cell population from ES cells
contrasted with the differentiated cell types produced when ES
cells differentiate spontaneously in response to LIF withdrawal
(Smith, 1991; Fig. 1C). However, within spontaneously
differentiated ES cell cultures a small proportion of EPL-like
colonies were seen (Fig. 1C), suggesting that EPL cells are a
normal derivative of ES cells. EPL cell morphology could be
maintained with extended culture of greater than 40 passages,
or 100 days (data not shown) and was dependent on the
continued presence of MEDII in the culture medium.
Withdrawal of MEDII and mLIF resulted in the generation of
an array of differentiated cell types (data not shown) similar to
those arising from spontaneous ES cell differentiation (Smith,
1991).
The transition of ES cells to EPL cells, in response to
MEDII, was demonstrated for a number of independently
derived ES cell lines including MBL5, D3, CCE, E14 and
CGR8 (data not shown). The appearance of EPL cells
generated from each ES cell line was comparable.
EPL cells express pluripotent cell markers
The pluripotent cells of the early mouse embryo and germ line,
and ES cells in culture, are characterised by expression of the
homeobox gene Oct4 (Rosner et al., 1990; Schöler et al., 1990;
Yeom et al., 1991), the cell surface antigen SSEA1 (Solter and
Knowles, 1978; Smith, 1992) and by alkaline phosphatase
activity (Hahnel et al., 1990; Pease et al., 1990). EPL cells were
formed by culturing ES cells in the presence of MEDII or
MEDII+mLIF, for 2, 4, 6 and 16 days, with passaging every 2
days. Northern analysis of RNA from these populations
showed expression of Oct4 at levels equivalent to the levels
seen in ES cells (Fig. 2A). Oct4 expression persisted, at levels
analogous to those seen in ES cells, for at least 16 days in the
presence of MEDII or MEDII+mLIF (Fig. 2A), suggesting that
the formation of EPL cells is not equivalent to the process of
spontaneous differentiation (Fig. 2A). In situ hybridisation of
ES cells and EPL cell monolayers with an Oct4 specific anti-
sense RNA probe showed Oct4 expression uniformly
distributed across the EPL cell colonies, and not restricted to
sub-populations of cells within the culture (Fig. 2B,C).
Sporadic differentiated cells within the population did not
express Oct4 (data not shown). Analysis of alkaline
phosphatase activity and SSEA1 distribution also showed
uniform expression by EPL cells (Fig. 2D,E; data not shown),
with down regulation in the differentiated cells (data not
shown). The uniform distribution of these pluripotent cell
markers in EPL cell cultures demonstrated the homogeneity of
the EPL cell population.
EPL cell formation is accompanied by establishment
of primitive ectoderm-like gene expression
The expression of pluripotent cell marker genes by EPL cells
suggested that these cells could be equivalent to a pluripotent
cell population of the early embryo (Schöler et al., 1990;
Hahnel et al., 1990), or possibly a differentiated cell lineage in
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Fig. 1. MEDII effects the transition of ES cells to EPL cells. ES cells
grown in medium containing mLIF (A) or 50% MEDII+mLIF (B)
after 4 days in culture. ES cells cultured in the presence of MEDII
show a characteristic morphology associated with the formation of
EPL cells. Bar, 50 m m. (C) ES cells were seeded at a density of 250
cells/cm2 in medium containing mLIF, 50% MEDII+mLIF, 50%
MEDII and without addition. After 5 days the cultures were stained
for alkaline phosphatase and haematoxylin, and the percentage of
ES, EPL and differentiated colonies determined. Alkaline
phosphatase positive colonies were subdivided into ES and EPL cell
colonies on the basis of morphology, differentiated colonies (D) were
determined as alkaline phosphatase negative. Plating efficiencies (%)
for each condition were 42.8±8.7 (mLIF); 47.26±2.6 (50%
MEDII+mLIF); 40.5±5.9 (50% MEDII); 41.4±6.6 (no addition).
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which Oct4 expression was not fully down-regulated (Pruitt,
1994). The pluripotent cell populations of the embryo can be
discriminated from differentiated cell lineages by
morphological and developmental criteria (Snow, 1977;
Beddington, 1983; Gardner, 1985) and by the temporal and
spatial expression of marker genes (Haub and Goldfarb, 1991;
Hébert et al., 1991; Rogers et al., 1991). The embryonic
equivalent of EPL cells was investigated by analysis of the
expression of marker genes that identify the pluripotent cell
populations of the embryo, and the differentiated cells of the
extra-embryonic lineages and gastrulating embryo.
Three genes, Fgf5, Rex1 and Gbx2, have been reported to be
differentially transcribed between cells of the ICM and
primitive ectoderm (summarised in Table 1). Fgf5 expression
is up regulated on the formation of primitive ectoderm from
the ICM (Haub and Goldfarb, 1991; Hébert et al., 1991),
whereas both Rex1 and Gbx2 expression can be detected in the
ICM but not in the primitive ectoderm by 6.5 d.p.c. (Rogers et
al., 1991; Bulfone et al., 1993; Chapman et al., 1997). The
expression of Fgf5 and Rex1 in ES and EPL cells was assessed
by northern blot (Fig. 2A; Table 1). Gbx2 expression was
analysed by RNase protection assay (Fig. 2F; Table 1). Fgf5
expression, which was barely detectable in ES cells, was
elevated 50-fold in EPL cells grown for 2 days in MEDII. Fgf5
expression increased in EPL cells with time in culture such that
maximal expression, representing a 340 fold induction of Fgf5,
was reached by day 6 (Fig. 2A) and persisted for at least 16
days in culture (Fig. 2A). Rex1 was expressed at high levels by
ES cells, but this expression was down regulated 50% within
2 days of EPL cell formation (Fig. 2A; Table 1). Rex1
expression was reduced further in EPL cells cultured for longer
periods of time such that EPL cells grown in MEDII for 6 days
showed a 5-fold reduction in Rex1 expression compared to ES
cells. Gbx2 expression was high in ES cells and maintained
Fig. 2. (A) Northern blot analysis of ES and EPL cell RNA. 20 m g of
total RNA, isolated from E14 ES cells, EPL cell derivatives cultured in
MEDII or MEDII+mLIF for 2, 4, 6, and 16 days (i), and
spontaneously differentiated ES cells cultured for 6 days in the absence
of exogenous factors (ii), was analysed for the expression of Fgf5,
Rex1, Oct4, and mGAP. Fgf5 transcripts were 2.7 and 1.8 kb (Hébert et
al., 1990), Rex1 1.9 kb (Hosler et al., 1989), Oct4 1.55 kb (Rosner et
al., 1990) and mGAP 1.5 kb. (B,C) In situ analysis of ES (B) and EPL
(C) cell layers for the expression of Oct4. (D,E) ES (D) and EPL (E)
cells were stained for the presence of alkaline phosphatase. (F) 10 m g
RNA from ES cells and EPL cells cultured for 2, 4 and 6 days in
MEDII+mLIF and MEDII was analysed for the expression of Gbx2,
Oct4 and mGAP by Rnase protection. (G) In situ analysis of EPL cells
for the expression of Fgf5. (H) 20 m g of total RNA from ES cells and
EPL cells maintained in MEDII+mLIF for 2 and 6 days was analysed
by northern for the expression of uvomorulin (Uvo). mGAP expression
was used to normalise RNA levels. Bars: 32 m m (B-E); 25 m m (F).
Table 1. Summary of the gene expression patterns of ES
cells and EPL cells compared to gene expression in the
ICM and primitive ectoderm of the embryo
Primitive
ES cells ICM EPL cells ectoderm
Oct4 + + + +
Alkaline phosphatase + + + +
Uvomorulin + + + +
Fgf5 - - + +
Rex1 high + low -
Gbx2 + + - -
Alphafetoprotein (AFP) - - - -
H19 - - - -
Evx1 - - - -
Brachyury - - - -
Genes differentially transcribed between these two cell populations have
been highlighted. RNA was isolated from ES cells and EPL cells grown in the
presence of MEDII for 2 days and analysed by northern blot for the
expression of Oct4, uvomorulin, Fgf5, Rex1, alphafetoprotein (AFP), H19,
Evx1 and Brachyury. Gbx2 expression was detected using RNA protection
assays. Alkaline phosphatase activity was detected using an enzymatic stain
on ES and EPL cell layers. Embryonic expression patterns were determined
by Rosner et al., 1990; Schöler et al., 1990; Yeom et al., 1991 (Oct4); Hahnel
et al., 1990 (alkaline phosphatase); Sefton et al., 1992 (uvomorulin); Haub
and Goldfarb, 1991 (Fgf5); Rogers et al., 1991 (Rex1); Bulfone et al., 1993;
Chapman et al., 1997 (Gbx2); Dziadek and Adamson, 1978 (AFP); Poirier et
al., 1991 (H19); Bastian and Gruss, 1990; Dush and Martin, 1992 (Evx1); and
Herrmann, 1991 (Brachyury).
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with 2 days of culture in MEDII, but was reduced with further
culture in MEDII to undetectable levels by day 6. The changes
in expression of Fgf5, Rex1 and Gbx2 were delayed when the
transition of ES to EPL cells was carried out in MEDII+mLIF
when compared to EPL cells formed in MEDII (Fig. 2A),
suggesting that LIF retarded the ES to EPL cell transition. The
persistence of EPL cell morphology and high levels of Fgf5
and Oct4 expression (Fig. 2A) demonstrated the ability of
MEDII to maintain EPL cells as a stable cell population and
was clearly distinct from the gene expression changes observed
during spontaneous differentiation of ES cells (Fig. 2A).
EPL cell monolayers, cultured for 4 days in MEDII, were
probed for Fgf5 expression using DIG-labelled anti-sense Fgf5
transcripts. Equivalent levels of Fgf5 specific staining were
seen in all EPL cells within the culture (Fig. 2G) confirming
both the uniformity of the ES to EPL cell transition and the
homogeneity of EPL cell populations.
The expression of uvomorulin, a cadherin expressed by the
pluripotent cells of the ICM and the primitive ectoderm but
down-regulated in cells of the primordial germ cell lineage
(Sefton et al., 1992), was assessed in ES and EPL cell cultures
by northern blot analysis. Uvomorulin expression was
maintained in EPL cells at levels equivalent to or greater than
those observed in ES cells (Fig. 2H) suggesting that these cells
did not represent an in vitro equivalent of primordial germ
cells.
Consistent with the expression pattern of pluripotent cell
markers EPL cells did not express detectable levels of marker
genes specific for the extra-embryonic lineages of the early
embryo (H19; Poirier et al., 1991; AFP; Dziadek and
Adamson, 1978;), the primitive streak (Evx1; Bastian and
Gruss, 1990; Dush and Martin, 1992) or nascent mesoderm
(Brachyury; Wilkinson et al., 1990; Herrmann, 1991) (Table 1;
data not shown).
The morphological transition of ES to EPL cells was found
to be accompanied by differential regulation of marker genes
that discriminate pluripotent cell populations in vivo. Although
gene expression in ES cells was equivalent to their origin from
the pluripotent cells of the pre-implantation embryo, EPL cells
expressed a repertoire of marker genes which is shared by only
one cell population of the early embryo, the primitive ectoderm
(Table 1).
ES and EPL cells represent distinct, but
interchangeable, cell states
EPL cells seeded and cultured in medium containing mLIF, but
not MEDII, were observed to adopt an ES cell-like colony
morphology, a process we termed reversion. Further, the
withdrawal of MEDII, in the presence of mLIF, from
established EPL cell colonies resulted in the formation of a
three-dimensional colony structure suggestive of the ES cell
phenotype (data not shown). Northern blot analysis was used
to examine the expression of Oct4, Fgf5 and Rex1 in ES, EPL
and reverted EPL cells. EPL cells cultured and passaged in
MEDII and MEDII+mLIF for 2, 4 and 6 days were reverted
by passaging the cells into medium containing mLIF alone for
6 days. Reverted EPL cells exhibited low Fgf5 expression and
high Rex1 expression, comparable to the gene expression
profile observed in ES cells and distinct from the expression of
high levels of Fgf5 and low levels of Rex1 in the parental EPL
cells (Fig. 3A). These data indicated that the phenotypic
reversion of EPL cells was accompanied by the establishment
of an ES cell gene expression profile. These data also
demonstrated a requirement for MEDII for both the
establishment and maintenance of EPL cell characteristics.
Clonal EPL cell lines were generated and reverted to ensure
that reversion was not a consequence of residual ES cells
within EPL cell populations. EPL cells, grown for 4 days in
medium containing MEDII but without added mLIF, were
seeded at limiting dilution in MEDII+mLIF to produce clonal
EPL cell colonies. Two clones were expanded in MEDII+mLIF
over 3 weeks before seeding into medium containing mLIF
alone or MEDII+mLIF. The resulting cultures were assessed
for the presence of ES cells, EPL cells and differentiated
colonies (Fig. 3B). A high proportion of cells from both lines
formed alkaline phosphatase positive colonies with ES cell
morphology in cultures seeded and maintained in mLIF alone
which were not seen in the cultures maintained in
MEDII+mLIF, indicating efficient reversion of the clonal lines.
Reverted EPL cells, but not EPL cells, were able to
contribute to chimeric mice following blastocyst
injection
Pluripotent cells from the pre- and post-implantation embryo
differ by the ability of the former but not the latter to contribute
to embryo development following blastocyst injection (Gardner,
1971; Rossant, 1977; Beddington, 1983; Brook and Gardner,
1997). ES cells retain the ability to contribute to all embryonic
and adult tissues (Robertson, 1986; Thomas and Capecchi,
1987). E14TG2a ES cells (Hooper et al., 1987) and their EPL
cell derivatives were tested for their ability to contribute to
chimeric mice when injected into CBA/C57 F2 blastocysts. The
contribution of ES cell and EPL cell derivatives to mouse
offspring was assessed by coat colour contribution and GPI
analysis of blood and tissues. E14TG2a ES cells contributed to
the development of 44% of injected blastocysts (Table 2). In
contrast, E14TG2a derived EPL cells, grown in MEDII without
added mLIF for 2 and 4 days such that EPL cell gene expression
was established, did not contribute to chimera formation as
assessed by coat colour of the 33 and 50 live born pups,
respectively (Table 2). GPI analysis of blood samples taken
from 20 of these mice also failed to detect any contribution from
the EPL cells. Analysis of 15 tissue samples taken from two
mice also failed to detect any EPL cell contribution. This could
not be explained by adverse effects of EPL cells on the viability
of injected blastocysts as the percentage of live born pups was
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Table 2. ES cells and reverted EPL cells, but not EPL cells,
contribute to the development of chimeric mice when
injected into CBA/C57 black host blastocysts
Blastocysts Pups % Chimera
injected born % Liveborn born
ES; E14TG2a 163 65 40 58
EPL; 2 65 33 50 0
EPL; 4 77 50 65 0
EPL; 2R 78 22 28 36
EPL; 4R 74 31 42 58
Summary of results from the injection of E14TG2a ES cells, their EPL cell
derivatives grown in 50% MEDII for 2 and 4 days (EPL;2 and EPL;4
respectively) and reverted EPL cells, formed by the culture of EPL cells in
medium containing mLIF but not MEDII for 6 days (EPL;2R and EPL;4R).
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comparable from blastocysts injected with ES cells and EPL
cells (Table 2).
The EPL cells used in the preceding blastocyst injection
experiments were reverted by culture in media containing
mLIF, but not MEDII, for 6 days (2R and 4R). These cells
contributed to embryonic development in 36% (2R) and 63%
(4R) of blastocysts injected (Table 1). GPI analysis of blood
and tissue samples taken from 10 and 2, respectively, of the
chimeric mice generated using reverted EPL cells established
that these cells were able to contribute to mesodermal,
endodermal and ectodermal derived cell lineages of the adult
mouse (data not shown). These data indicated that the ES to
EPL cell transition resulted in cells of differing developmental
capabilities, reflected in the ability of ES cells, but not EPL
cells, to contribute to development when introduced into a host
blastocyst. The ability of reverted EPL cells to contribute to
chimera development suggests that this loss in chimera
forming ability by EPL cells can not be attributed to a loss of
pluripotence on EPL cell formation.
Soluble biological factors within MEDII are
responsible for the ES to EPL cell transition
Serum free medium conditioned by Hep G2 cells for 3-4 days
(sfMEDII) was shown to cause the ES to EPL cell transition
in a manner analogous to MEDII (data not shown). SfMEDII
was separated into two fractions by ultrafiltration through a
3· 103 Mr cut-off membrane (Centricon-3 unit; Amicon). Both
fractions were assayed for EPL cell forming activity, defined
as the ability to cause the complete conversion of D3 ES cells
to alkaline phosphatase positive EPL cells in the presence of
mLIF. ES cells seeded into the retained fraction (>3 · 103 Mr),
at concentrations equivalent to 50% MEDII, did not form EPL
cells (Fig. 4A). ES cells seeded into the eluted fraction (<3· 103
Mr), at concentrations equivalent to 50% MEDII, gave rise to
an array of colony morphologies including ES, EPL and
differentiated. The presence of ES cells was uncharacteristic of
the ES to EPL cell transition and demonstrated that the eluted
material alone was unable to induce EPL cell formation (Fig.
4A). Seeding of ES cells into medium containing both the
retained and eluted fractions resulted in uniform EPL cell
formation (Fig. 4A), equivalent to that seen for sfMEDII.
These data indicated that two separable biological factors were
required for the conversion of ES to EPL cells.
The retained and eluted fractions of sfMEDII were partially
purified by column chromatography. The retained fraction was
bound to a Resource Q anion exchange column and eluted with
an increasing salt gradient. Individual fractions were assessed
for EPL cell forming activity on ES cells in the presence of
mLIF and the presence and absence of the eluted fraction. In
the absence of the eluted fraction the ES to EPL cell transition
could not be detected in any fraction. EPL cell forming activity
was shown to elute from the column between 250 and 350 mM
NaCl when assayed in the presence of the eluted fraction (Fig.
4B). Partial purification of the smaller activity was achieved by
normal phase chromatography on a Waters radial-pak phase
chromatography cartridge. Column fractions were assayed for
EPL cell forming activity on ES cells in the presence and
absence of the retained fraction. In the presence of the retained
Fig. 3.(A) Northern blot analysis of EPL cells
and reverted EPL cells. 20 m g of total RNA from
EPL cells, cultured in the presence of MEDII or
MEDII+mLIF for 2, 4 and 6 days, and their
reverted derivatives, reverted in medium
containing mLIF alone (2R, 4R and 6R), was
analysed by northern blot for the expression of
Fgf5, Rex1, Oct4 and mGAP. (B) Clonal EPL cell
lines #1 and #2 were seeded at a density of 250
cells/cm2 and 500 cells/cm2, respectively, into
medium containing mLIF and 50% MEDII +
mLIF. After 5 days the cultures were stained for
alkaline phosphatase and the percentage of ES,
EPL and differentiated colonies determined.
Alkaline phosphatase positive colonies were
subdivided into ES and EPL cell colonies on the
basis of morphology, differentiated colonies (D)
were determined as alkaline phosphatase
negative. Plating efficiencies (%) were 18.4±2.62
(clone #1, mLIF); 34.8±4.56 (clone #1, 50%
MEDII + mLIF); 20.4±1.71 (clone #2, mLIF);
31.16±2.93 (clone #2, 50% MEDII + mLIF).
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fraction, EPL cell forming activity was detected eluting from
the column at 70% water:30% methanol:acetonitrile (Fig. 4C).
In the absence of the retained fraction the ES to EPL cell
transition was not observed. The ability to retain EPL cell
forming activity on chromatographic columns indicates that at
least two particulate activities within MEDII are responsible
for the transition of ES to EPL cells.
A role for gp130 signalling in EPL cell maintenance
The increased level of differentiated cell colonies seen in EPL
cell cultures without added mLIF when compared to cultures
with added mLIF (Figs 1C, 5), suggested a possible role for
LIF, or other cytokines which signal through gp130, in the
maintenance of EPL cells. Antibodies to mouse gp130 (RX-
19), which neutralises the activity of mLIF, hOSM, hIL-6 and
hIL-11, but not hLIF, on myeloid leukemic M1 cells and ES
cells (Koshimizu et al., 1996; Lake, 1996), and to hLIF (R&D
Systems), which neutralises hLIF activity (Lake, 1996), were
used to assess the role of gp130 signalling in EPL cell
maintenance.
While EPL cell formation was observed in the presence of
anti-gp130 (10 m g/ml) or anti-hLIF (10 m g/ml) antibodies, the
addition of anti-hLIF antibodies resulted in marked
destabilisation of EPL cells compared to cells cultured in
MEDII alone (Fig. 5). This suggested that the presence of hLIF
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Fig. 4. Two active components are required for the formation of EPL
cells. (A) sfMEDII was separated via ultrafiltration on a centricon-3
unit into two fractions; the retained fraction, containing all medium
components of >3 · 103 Mr and the eluted fraction, containing
smaller, <3· 103 Mr, components. ES cells were seeded at a density
of 250 cell/cm2 into medium containing the eluted fraction, the
retained fraction or the retained and eluted fractions together and
compared to mLIF. After 5 days the cultures were stained for
alkaline phosphatase and the percentage of ES, EPL (alkaline
phosphatase positive) and differentiated colonies (alkaline
phosphatase negative; D) determined. Plating efficiencies (%) were
48.4 (eluted fraction); 41.6 (retained fraction); 49.2 (eluted and
retained fractions); 32.8 (mLIF). (B,C) Anion exchange
chromatography of the retained fraction (B) and Normal phase
chromatography of the eluted fraction (C). EPL cell forming activity
is indicated in each case by the black bar. Buffer B was 1 M NaCl in
50 mM Tris-Cl, pH 8.5, for anion exchange chromatography (B) and































































Fig. 5. hLIF is required for the maintenance of EPL cells in culture.
ES cells were seeded at a density of 250 cells/cm2 into medium
containing 50% MEDII or 50% MEDII+mLIF (1000 units/ml), hLIF
(1000 units/ml), anti-hLIF antibodies (10 m g/ml), hLIF (1000
units/ml) and anti-hLIF antibodies (10 m g/ml), mLIF (1000 units/ml)
and anti-hLIF antibodies (10 m g/ml), anti-gp130 antibodies (10
m g/ml) or hLIF (1000 units/ml) and anti-gp130 antibodies (10
m g/ml). After 5 days in culture colonies were stained for alkaline
phosphatase and the percentage of EPL cell containing colonies
(EPL) and differentiated colonies (D) determined. Plating
efficiencies (%) for each condition were 32.5±1.5 (50% MEDII);
39.8±1.3 (50% MEDII+mLIF); 35.0±0.2 (MEDII + hLIF); 25.5±1.0
(MEDII + anti-hLIF antibodies); 28.8±3.8 (MEDII + hLIF + anti-
hLIF antibodies); 40.0±0.5 (MEDII + mLIF + anti-hLIF antibodies);
36.8±3.3 (MEDII + anti-gp130 antibodies); 36.3±2.3 (MEDII + hLIF
+ anti-gp130 antibodies).
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in MEDII, but not mLIF expressed by the cells, was important
EPL cell maintenance. The addition of both anti-hLIF
antibodies and 1,000 units of mLIF (ESGRO) reduced the
levels of differentiation to those seen in EPL cell cultures
formed in MEDII+mLIF, demonstrating that gp130 signalling
was able to restore EPL cell stability in culture.
ES cells were seeded into medium containing MEDII, anti-
hLIF antibodies (10 m g/ml) and mLIF at concentrations
between 10 and 1000 units/ml (ESGRO; Amrad). EPL cell
maintenance was achieved with the addition of between 50 and
100 units/ml of mLIF (data not shown), 10- to 20-fold less than
the 1000 units/ml required for the maintenance of ES cells
(Williams et al., 1988: J. Rathjen and J. Lake, unpublished).
DISCUSSION
MEDII was identified as a conditioned medium which caused
the transition of ES cells to a novel cell population we have
termed early primitive ectoderm-like, or EPL, cells. Two
separable factors contained within MEDII were required for
both the formation and maintenance of EPL cells. Maintenance
of EPL cells also required LIF, at concentrations 10- to 20-fold
lower than required by ES cells. The ES cells used in this paper
were shown to be comparable with cells of the ICM in gene
expression and ability to contribute to chimera formation. In
contrast, characterisation of EPL cells showed them to be a cell
population which express pluripotent cell markers but which
were distinct from ES cells in terms of cell morphology, gene
expression, cytokine requirements and the inability of EPL
cells to contribute to chimera development following blastocyst
injection.
A novel cell population with properties equivalent to
the primitive ectoderm
The expression patterns of pluripotent cell markers Oct4,
alkaline phosphatase and uvomorulin identified EPL cells as
equivalent to pluripotent cells of the early embryo, distinct
from primordial germ cells. Consistent with this, EPL cells did
not express marker genes associated with cell lineages
determined at gastrulation or the extraembryonic lineages of
the embryo. Conversion from ES to EPL cells was found to be
accompanied by an increase in Fgf5 expression and a decrease
in both Gbx2 and Rex1 expression. Fgf5 is not expressed by
the pluripotent cells of the ICM, but has been detected within
cells of the epiblast later, at 5.25 d.p.c., where it persists until
differentiation (Haub and Goldfarb, 1991; Hébert et al., 1991).
Fgf5 is also expressed by P19 EC cells, which have been
proposed to be similar to the primitive ectoderm by virtue of
their morphology, gene expression (van den Eijnden-van Raaij
et al., 1991; Rogers et al., 1991) and differentiation potential
(Rossant and McBurney, 1982; Rudnicki and McBurney,
1987). Rex1 is expressed by the ICM of 4.5 d.p.c. embryos and
ES cells, but not in the primitive ectoderm of 6.0 d.p.c.
embryos or P19 EC cells (Rogers et al., 1991). The embryonic
expression pattern of Rex1 has been further refined and the
down regulation in expression shown to have occurred by 5.25
d.p.c. (T. Pelton and P. D. Rathjen, unpublished). Similarly,
expression of Gbx2 has been detected in the ICM of the 4.0
d.p.c. blastocyst but not in the primitive ectoderm of embryoid
bodies or the 6.5 d.p.c. embryo (Bulfone et al., 1993; Chapman
et al., 1997). Gbx2 expression is reinitiated in the three primary
germ layers following gastrulation (Bulfone et al., 1993;
Bouillet et al., 1995). The up regulation of Fgf5 exhibited by
EPL cells suggests an equivalence with cells of the primitive
ectoderm post 5.25 d.p.c. Likewise, down regulation of Rex1
and Gbx2 expression during the formation of EPL cells
supports the identification of EPL cells as primitive ectoderm-
like. Taken together the gene expression pattern suggests the
embryonic equivalent of EPL cells occurs around 5.25 d.p.c.,
or immediately after cavitation of the pluripotent cell mass,
coinciding with the appearance of early primitive ectoderm.
The acquisition of primitive ectoderm-like gene expression
by EPL cells was not immediate but occurred gradually over
time. The progressive increase in Fgf5 expression in EPL cell
cultures was similar to the kinetics of Fgf5 up regulation in
embryoid bodies, where Fgf5 expression has been observed to
increase as the primitive ectoderm matures (Hébert et al.,
1991). The similarities with primitive ectoderm formation in
embryoid bodies suggest that the progressive maturation of
primitive ectoderm gene expression during EPL cell formation
may be reflected in vivo. A similar gradual alteration in
pluripotent cell identity has been proposed for cells of the ICM,
which show a progressive restriction in ability to form
extraembryonic tissues, such as the trophectoderm, when
differentiated in vitro (Smith, 1992).
The establishment of Fgf5, Gbx2 and Rex1 gene expression
patterns was delayed in EPL cells formed and maintained in
the presence of MED+mLIF. Several lines of evidence suggest
that LIF can delay the development of pluripotent cells both in
vitro and in vivo. The formation of primitive ectoderm during
embryoid body differentiation of ES cells has been shown to
be inhibited by the presence of exogenous LIF (Shen and
Leder, 1992). Furthermore, the pluripotent cells of chimeric
mice overexpressing the M-LIF cDNA showed abnormal
proliferation and did not undergo differentiation into
mesoderm (Conquet et al., 1992). The ability of LIF to inhibit
the development of EPL cell characteristics further underlines
the relationship between the primitive ectoderm and EPL cells.
The assignation of EPL cells as primitive ectoderm-like is
supported by the inability of EPL cells to contribute to the
development of chimeric mice when introduced into a host
blastocyst. This deficiency does not appear to be attributable
to a loss of pluripotence as reverted EPL cells readily
contributed to mouse development. Experiments carried out by
Beddington (1983) have demonstrated a similar limitation in
ability of pluripotent cell populations of the post-implantation
embryo to contribute to the formation of chimeric mice. These
data suggest that development of the ICM to the primitive
ectoderm, which occurs at the time of implantation, alters the
pluripotent cells such that they can no longer assimilate with
the cells of the ICM or partake in development when
introduced at this developmentally inappropriate stage.
MEDII action parallels primitive ectoderm formation
Formation of the primitive ectoderm in the mouse embryo
commences at the time of implantation of the blastocyst into the
uterine wall and results in the formation of a cup shaped pseudo-
stratified epithelium of pluripotent cells lining the proamniotic
cavity. Primitive ectoderm formation is a pivotal developmental
event resulting in the establishment of a population of cells
which act as a substrate for further differentiation. In vitro, as in
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vivo, the formation of primitive ectoderm appears to be an
obligatory intermediate in the differentiation of ES cells into
embryonic cell lineages (Shen and Leder, 1992).
Although several gene ablation experiments have identified
genes involved in proliferation and maintenance of the
primitive ectoderm (Chen et al., 1994; Spyropoulos and
Capecchi, 1994; Feldman et al., 1995; Mishina et al., 1995;
Winnier et al., 1995; Hakem et al., 1996; Hogan, 1996; Liu et
al., 1996; Duncan et al., 1997) little is known of the origin or
biochemical identity of the signals responsible for induction of
primitive ectoderm in the embryo.
Several lines of evidence suggest that signalling from the
visceral endoderm is required for primitive ectoderm
induction. Disruption of the Evx1 gene (Spyropoulos and
Capecchi, 1994) results in disruption of primitive ectoderm
formation at the time of implantation. At this time, Evx1
expression is restricted to visceral endoderm (Spyropoulos and
Capecchi, 1994), suggesting that the loss of Evx1 expression
within the visceral endoderm prevented primitive ectoderm
induction. Coucouvanis and Martin (1995) investigated
formation of the proamniotic cavity and primitive ectoderm in
early rodent embryogenesis using embryoid bodies as an in
vitro model. They proposed that cavitation within the epiblast
was a result of apoptosis in response to a ‘death’ signal
emanating from the visceral endoderm. Survival of the outer
cells, which proliferate to form the primitive ectoderm, was
ensured through contact with a ‘survival’ signal located on the
basement membrane between the pluripotent cells and visceral
endoderm. These experimental systems implicate signals
emanating from the neighbouring visceral endoderm cell layer,
possibly located within the intervening basement membrane in
the establishment and maintenance of primitive ectoderm.
In this regard it is interesting that EPL cells arise from ES
cells in response to factors expressed by a hepatic cell line.
Although visceral endoderm and liver are derived from different
cell lineages, the gene expression profiles of the two cell types
have been found to be similar (Meehan et al., 1984). A
preliminary characterisation of sfMEDII showed the presence
of two active components within the media which could be
readily separated by standard separation techniques. Further
characterisation of the factors suggests they comprise a large
molecular mass protein (retained fraction; M. Bettess and P. D.
Rathjen, unpublished) and a small peptide (eluted fraction; J.
Washington and P. D. Rathjen, unpublished). The formation and
maintenance of EPL cells required both of these factors. A more
detailed understanding of the active factors within MEDII may
provide an alternative route for the identification factors
involved in primitive ectoderm induction within the embryo.
The relationship between the inductive factors found in
MEDII, and factors previously described in the literature to
have a role in primitive ectoderm, biology is unclear. However,
parallels can be drawn between the two factor model proposed
by Coucouvanis and Martin (1995), which postulates the
existence of small, diffusible signal derived from the visceral
endoderm and a second signal associated with the extra-
cellular matrix.
The ES to EPL cell transition reveals distinct,
interconvertible cell states
The transition between ES cells and EPL cells was a reversible
process as ES cells could be generated from EPL cells by the
withdrawal of MEDII and the maintenance of LIF within the
culture. Reverted EPL cells grew as compact domed colonies,
equivalent to ES cell colonies in morphology, gene expression
and ability to contribute to the formation of chimeric mice
following blastocyst injection. The ability of EPL cells to revert
to ES cells suggests that the formation of EPL cells is not an
irreversible differentiation event but a process in which closely
related and interchangeable cell states are adopted in response
to specific signals. The existence of distinct cell states has been
evidenced by differential gene expression, but more
importantly by developmental reprogramming of the cells both
in vitro and in vivo. A similar phenomenon has been described
for other pluripotent cell types in vitro. Primordial germ cells,
from both the migratory germ cell population and the gonadal
population, require a combination of LIF, stem cell factor and
bFGF for initial in vitro culture but extended culture can be
achieved as ES cell-like cells in LIF alone (Matsui et al., 1992;
Resnick et al., 1992). Based largely on these observations,
Rossant (1993) has predicted that all the pluripotent cells of
the mammalian embryo can be cultured as a ‘basal’ ES/EC
pluripotent cell population. The interconvertibility of
pluripotent cell populations may underlie the ability of the
early mouse embryo to reprogram development in response to
environmental insult (Snow and Tam, 1979; Smith, 1992).
The initial events leading to primitive ectoderm formation
from the ICM occur between 4.75 and 5.5 d.p.c. of mouse
embryogenesis, at a time when analysis of the embryo is
hampered by the small size and inaccessibility of the embryo
within the uterine environment. The elucidation of many of the
molecular processes involved at this critical stage of
embryogenesis requires in vitro models of both the primitive
ectoderm and gastrulation. ES cells to date have proved an
intractable model for the understanding of many of these
processes. The formation of EPL cells from ES cells is the first
demonstration of uniform differentiation of ES cells in
response to biological factors. Resembling closely the
primitive ectoderm, EPL cells demonstrate the ability of
pluripotent cells to adopt distinct, interchangeable states
determined by the presence and absence of factors. EPL cells
can be manipulated and studied in vitro and will allow more
precise modelling of the processes of early mammalian
embryogenesis, in particular the processes of pluripotent cell
development and the subsequent events of gastrulation. MEDII
provides an alternative route for the biochemical identification
of factors involved in the induction and maintenance of the
primitive ectoderm in vivo. Further, EPL cells represent a first
step in the development of lineage specific differentiation
protocols for ES cells.
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